Polyradiculoneuropathy
Showing 1 - 25 of 132
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Trial (Panzyga)
Not yet recruiting
- Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Sep 2, 2022
GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Durham, North CarolinaRTI Health Solutions
Jun 14, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)
-
Nagoya, Aichi, Japan
- +16 more
Feb 2, 2023
Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Vasculitic Neuropathy (Disorder) Trial in
Active, not recruiting
- Peripheral Neuropathy
- +5 more
- Biopsy + Nerve Repair
- Biopsy Only
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 25, 2023
Intravenous Immunoglobulin Treatment in Chronic Inflammatory
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Scottsdale, Arizona
- +13 more
Mar 31, 2022
Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide
Recruiting
- Healthy
- +2 more
- PF-06755347 intravenous healthy participant
- +4 more
-
New Haven, Connecticut
- +5 more
Dec 29, 2022
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Nice (Ultrasound UHF peripheral nerves, Electro myography
Completed
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Ultrasound UHF peripheral nerves
- Electro myography surface nerves
-
Nice, FranceCHU de Nice
May 5, 2022
Predict Intravenous Immunoglobulin Responders in Chronic
Suspended
- CIDP
- CIDP treated (IVIG)
-
Bordeaux, Aquitaine, France
- +17 more
Dec 23, 2021
Polyneuropathy, Impairments and Physical Activity - The
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- +8 more
- Validity and reliability of outcome measures in polyneuropathy
- Healthy controls
- (no location specified)
Sep 15, 2023
RWE-based Treatment Patterns and Outcomes in CIDP
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- +2 more
- No intervention. Retrospective observation only.
-
Salford, United KingdomNorthern Care Alliance NHS Foundation Trust
Jul 7, 2023
Disease Activity in Chronic Inflammatory Demyelinating
Recruiting
- CIDP
- Smartwatch (Withings Scanwatch)
-
Duesseldorf, Northrhine-Westphalia, GermanyMedical Faculty, Heinrich-Heine-University
Feb 1, 2023
High Frequency Ultrasound in Demyelinating Polyneuropathies
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- high frequency ultrasound
-
Nice, FranceNice University Hospital
Jul 28, 2021
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Clinical examination, Functional scales, Walking test)
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Clinical examination
- +2 more
- (no location specified)
Aug 5, 2022
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
- +2 more
-
Boca Raton, Florida
- +1 more
Jan 31, 2023
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- VitalStim 400
- VitalStim400
-
Atlanta, GeorgiaCenter for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022
Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)
No longer available
- Chronic Inflammatory Demyelinating Polyneuropathy
- HB-adMSCs
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Sep 20, 2022
Clinical and Electrophysiological Patterns of Chronic Dysimmune
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Jan 20, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Rituximab (genetical recombination)
- Placebo
-
Nagoya, Aich, Japan
- +3 more
Aug 19, 2021
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA)
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
-
Phoenix, Arizona
- +34 more
Mar 21, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- SAR445088 (IV)
- SAR445088 (SC)
-
Los Angeles, California
- +28 more
Aug 24, 2022
Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)
Withdrawn
- Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Nov 2, 2021